Abstract: The present disclosure provides methods for treating a mammal that has endometriosis using a CHRH1 antagonist composition. In some embodiments, the CHRH1 antagonist is antalarmin or an equivalent.
Type:
Grant
Filed:
February 28, 2019
Date of Patent:
August 4, 2020
Assignees:
PONCE MEDICAL SCHOOL FOUNDATION, INC., THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Inventors:
Annelyn Torres-Reveron, Caroline B. Appleyard, Idhaliz Flores